Gary Peters is not running again. His Senate seat is open, his political career is winding down, and the online chatter about him right now is mostly voters in Michigan sorting out who comes next. What Peters is still doing, apparently, is trading stocks. Three disclosures hit the tape on April 23, 2026: a sale of Corteva, a purchase of J.M. Smucker, and a purchase of PepsiCo. One of those lands squarely inside the jurisdiction of his own Appropriations subcommittee. The clock on his Senate career may be running out. His brokerage account didn't get the memo.
The Exit Lane and the Open Positions
The social conversation around Peters right now is almost entirely about succession. Michigan activists are already picking sides in the open-seat race, and Peters himself is being treated as a footnote to his own career. One current in the commentary paints him as a reliable vote for defense budgets and Trump-era nominees, a Democrat his own base has soured on heading out the door.
That framing is useful context. A senator in his final stretch has less political accountability than at any other point in his career. No reelection calculus. No constituent pressure worth sweating. The disclosures he files now are a purer read on his personal financial judgment than anything he filed in a campaign year.
So what does that judgment look like? On April 23, Peters sold Corteva (ticker: CTVA) in the $15,000-$50,000 range, bought J.M. Smucker (SJM) in the $1,000-$15,000 range, and bought PepsiCo (PEP) in the $15,000-$50,000 range. All three trades on the same day. All three companies with some relationship to the food, agriculture, and consumer goods space.
The committee question is worth stating plainly: Peters sits on the Senate Appropriations subcommittee covering Agriculture, Rural Development, the Food and Drug Administration, and Related Agencies. Corteva is an agricultural chemicals and seeds giant. PepsiCo is a food and beverage conglomerate. Both fall within the general orbit of what his subcommittee funds and oversees.
The CTVA Sale: The One With the Flag
The Corteva trade is the one that draws the most attention from a committee-overlap standpoint. Peters sold $15,000-$50,000 of CTVA on April 23. Corteva's business, for readers who don't follow agricultural inputs: seeds, crop protection chemicals, and the broader ecosystem of products that flow through the exact pipeline his Appropriations subcommittee is positioned to influence through funding and regulatory riders.
The alpha record on that trade is negative. Per Blind Trust's full disclosure tracking, the CTVA sale posted a 30-day excess return of -5.6% against the S&P 500. In plain terms: he sold, the stock underperformed the market in the 30 days that followed, which means the sale looks fine in hindsight on price alone. Whether the timing reflected anything beyond ordinary portfolio management is not something the filing tells you.
What the filing does tell you: a senator with direct appropriations authority over agricultural agencies sold a major agricultural company's stock. Members are required to disclose. They are not required to divest, recuse, abstain, blush, or look up from their phones.
PepsiCo: The Other Overlap
The PepsiCo purchase on the same date carries its own committee-overlap flag. Peters bought $15,000-$50,000 of PEP on April 23. PepsiCo sits inside the Consumer, Food and Beverage overlap category in Blind Trust's tracking. Peters's Appropriations subcommittee covers the FDA, which regulates food labeling, ingredient safety, and a range of issues that touch PepsiCo's product portfolio directly.
The 30-day alpha on the PEP purchase: +0.4%. Essentially flat against the market. Not a score, not a disaster. The J.M. Smucker buy (SJM, $1,000-$15,000) has no committee overlap flagged in the data, which makes it the least interesting of the three trades from a conflict-of-interest read. It's just a trade.
The receipts are public. Make of them what you make of them.
The Full Scorecard Is not Pretty
Blind Trust scores Peters's disclosed trades against 30-day S&P 500 performance. The full sample: 5 positive results out of 9 scored trades. Mean 30-day alpha across all scored trades: -3.4%. That's a senator who, on average, has left money on the table relative to just owning an index fund.
The best trades in the sample have no committee overlap. A Stanley Black and Decker (SWK) purchase on January 12, 2026 posted +9.2% alpha. A W.P. Carey (WPC) purchase on the same date posted +7.3%. A Conagra Brands (CAG) purchase from November 2025 posted +3.8%. None of those carry an oversight angle per the data.
The worst trades: an Organon (OGN) sale from October 2025 posted -39.9% alpha, meaning he sold and the stock dramatically outperformed the market in the 30 days that followed. An Intel (INTC) sale in December 2025 posted -5.8% alpha and carries a committee overlap flag under Technology, which falls within his Commerce, Science, and Transportation committee jurisdiction. The CTVA sale, -5.6%, sits in the same overlap territory on the Agriculture side.
The pattern in the committee-overlap trades specifically: Verizon (VZ), purchased December 2025 with a Telecommunications overlap, posted -1.4% alpha. PEP, +0.4%. CTVA, -5.6%. INTC, -5.8%. Four committee-overlap trades. Zero of them beat the market by more than half a percent. The average alpha on the committee-overlap subset is negative. If Peters has access to committee-level insight that helps him trade, the results so far don't show it.
The Votes Alongside the Trades
Recent floor votes from Peters are a mix of Democratic procedural positions. On June 3, 2026, he voted Yea on a motion to proceed on a Congressional Review Act resolution to block an EPA rule repealing emission standards for coal- and oil-fired power plants. The motion failed. On June 5, he voted Nay on the Secure America Act, which passed. He voted Yea on two procedural votes advancing the 21st Century ROAD to Housing Act in mid-June.
None of those floor votes carry a direct committee-overlap angle with his April 23 trades. The trades came before those votes, and the bills involved don't map to the food, agriculture, or consumer goods space. A floor vote on housing or immigration falls well outside Peters's Appropriations agriculture subcommittee and his Commerce committee assignments. Worth stating clearly: floor votes on bills outside a member's committee jurisdiction are just votes. The April 23 trades and the June votes are not the same story.
The story is simpler: a senator finishing out his final term, sitting on committees with oversight of agricultural agencies and telecommunications, disclosed trades in companies that fall inside those jurisdictions. The trades were not timed to any vote we can identify. The alpha on the overlap trades is negative. And the overall scorecard sits at 5-for-9 with a -3.4% mean.
Lame Duck, Open Account
The retiring-senator dynamic is worth sitting with. Peters has no 2026 race to run. The open-seat scramble consuming Michigan Democratic politics right now is someone else's problem. His use inside the Senate diminishes with every month left on the calendar. What remains constant is his committee seat, his access to appropriations processes, and his obligation to disclose.
Three trades on April 23 in food and agriculture stocks, filed by a senator on the Agriculture Appropriations subcommittee, during a period when he has nothing electoral left to lose. The system asks him to disclose, and he did. The system asks nothing further. That's the rule.
Yes, really.
Peters's full trade history is on Blind Trust. Nine trades scored, five positive, four negative, mean alpha of -3.4%. The committee-overlap trades are flagged. The calendar is what it is.